Shanghai Rendu Biotechnology Co., Ltd. (SHA:688193)
China
· Delayed Price · Currency is CNY 35.20
-0.24 (-0.68%)
At close: Apr 25, 2025, 2:57 PM CST
SHA:688193 Market Cap
SHA:688193 has a market cap or net worth of 1.39 billion as of April 29, 2025. Its market cap has increased by 5.62% in one year.
Market Cap
1.39B
Enterprise Value
617.46M
Revenue
177.35M
Ranking
n/a
PE Ratio
n/a
Stock Price
35.20
Market Cap Chart
Since March 30, 2022, SHA:688193's market cap has decreased from 2.59B to 1.39B, a decrease of -46.50%. That is a compound annual growth rate of -18.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2025 | 1.39B | 0.14% |
| Dec 31, 2024 | 1.38B | -23.32% |
| Dec 29, 2023 | 1.80B | -3.42% |
| Dec 30, 2022 | 1.87B | -27.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 317.74B |
| Shenzhen Mindray Bio-Medical Electronics | 259.78B |
| WuXi AppTec | 165.20B |
| Zhangzhou Pientzehuang Pharmaceutical., | 123.73B |
| Aier Eye Hospital Group | 122.07B |
| Sichuan Biokin Pharmaceutical | 114.29B |
| Yunnan Baiyao Group Co.,Ltd | 103.33B |
| Shanghai United Imaging Healthcare | 102.12B |